type here...

Mark Rosenberg

Mark Rosenberg is a health policy expert and the CEO of JustMedicine, Inc., a non-profit organization dedicated to developing creative solutions to pharmaceutical market inefficiencies that decrease consumer welfare.
Antitrust and Competition

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Rena Conti
Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but they are...
Antitrust and Competition

The Generic Pharmaceutical Market Needs Competition. Non-Profits Can Provide It

Mark Rosenberg
JustMedicine is a non-profit that aims to introduce competition into the generic drug market by sponsoring generic entrants. The organization’s CEO explains why non-profit...

Latest news

View All

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.